References

  1. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. AntivirTher. 1998; 3(Suppl3): 1-9. PubMed | Google Scholar

  2. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007; 46(3): 922-938. PubMed | Google Scholar

  3. Merli MG, Nicolini S, Angeloni S, Rinaldi V, De Santis A, Merkel C et al. "Incidence and natural history of small esophageal varices in cirrhotic patients." Journal of Hepatology. 2003; 38(3): 266-272. PubMed | Google Scholar

  4. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R et al. Betablockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005; 353(21): 2254-2261. PubMed

  5. Groszmann RJ, Bosch J, Grace ND, Conn HO, Gracia-Tsao G, Navasa M, Alberts J. Hemodynamic events in a prospective randomized trial of Propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990; 99(5): 1401-1407. PubMed | Google Scholar

  6. The North Italian Endoscopic for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med. 1988; 319(15): 983-9. PubMed | Google Scholar

  7. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history and influence on survival. Gastroenterology. 1989; 96(6): 1552-9. PubMed | Google Scholar

  8. D'Amico G, De Franchis R, a cooperative study group. Upper digestive bleeding in cirrhosis: post-therapeutic outcome and prognostic indicators. Hepatology. 2003; 38(3): 599-612. PubMed | Google Scholar

  9. Villanueva C, Piqueras M, Aracil C, Gomez C, Lopez-Balaguer JM, Gonzalez B et al. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol. 2006; 45(4): 5607-7. PubMed | Google Scholar

  10. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology. 2008; 47(5): 1604-14. PubMed | Google Scholar

  11. Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982; 82(5): 968-73. PubMed | Google Scholar

  12. Fugger R, Herbst F, Mirza D. Combined sclerotherapy and operation for the treatment of bleeding oesophageal varices. Eur J Surg. 1992; 158(9): 485-9. PubMed | Google Scholar

  13. GraVeo M, BuVoli F, Lanzani G, Donato F, Cesari P, Benedini D et al. Survival after endoscopic sclerotherapy for esophageal varices in cirrhotics. Am J Gastroenterol. 1994; 89(10): 1815-1822. PubMed | Google Scholar

  14. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981; 80(4): 800-9. PubMed | Google Scholar

  15. Farooqi JI, Ahmed H, Ikramullah Q, Ahmed F, Masood-ur R. Predictors of esophageal varices in patients of liver cirrhosis. JPMI. 2007; 21(1): 60-64. Google Scholar

  16. D'Amico G, PagliaroL, Boch J, Patch D. Pharmacological treatment of portal hypertension: an evidence-based approach. Seminars in Liver Disease. 1999; 19(4): 475-505. PubMed | Google Scholar

  17. Archampong TNA, Tachi K, Agyei AA, Nkrumah KN. The Significance of variceal haemorrhage in Ghana: a retrospective review. Ghana Med J. 2015; 49(4): 142-146. PubMed | Google Scholar

  18. Mahassadi AK, Bathaix FY, Assi C, Bangoura AD, Allah-Kouadio EE, Kissi HY et al. Usefulness of noninvasive predictors of oesophageal varices in black African cirrhotic patients in Cote d'Ivoire (West Africa). Gastroenterology Res Pract. 2012; 2012: 216390. PubMed | Google Scholar

  19. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, William R. Transection of the oesophagus for the bleeding of the oesophageal varices. Br J Surg. 1973; 60(8): 646-9. PubMed | Google Scholar

  20. Cales P, Zaboto B, Meskens C, Caucanas JP, Vinel JP, Desmorat H et al. Gastro-esophageal endoscopic features in cirrhosis: observer variability, inter-associations and relationship to hepatic dysfunction. Gastroenterology. 1990; 98(1): 156-162. PubMed | Google Scholar

  21. Blankson A, Wiredu EK, Gyasi RK, Adjei A, Tettey Y. Sero -prevalence of hepatitis B and C viruses in cirrhosis of the liver in Accra, Ghana. Ghana Med J. 2005; 39(4): 132-137. Google Scholar

  22. Friedman SL. Hepatic fibrosis. In: Schiff ER, Sorrell MF and Maddrey WC eds. Schiff's Diseases of the Liver. 8th ed. Philadelphia, Pa: Lippincott-Raven. 1999; 371-385.

  23. Giannini EG, Botta F, Borro P, Dulbecco P, Testa E, Mansi C et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validati on study based on follow-up. Dig Liver Dis. 2005; 37(10): 779-85. PubMed | Google Scholar

  24. Mattos AZ, Mattos AA, Vianna FF, Musskopf MI, Pereira-Lima JC, Maciel AC. Platelet count/spleen diameter ratio: analysis of its capacity as a predictor of the existence of esophageal varices. Arq Gastroenterol. 2010; 47(3): 275-278. PubMed | Google Scholar

  25. Ofori-Asenso R, Agyeman AA. Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015). BMC Infect Dis. 2016; 16: 130. PubMed | Google Scholar

  26. Agyeman AA, Ofori-Asenso R, Mprah A, Ashiagbor G. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysis. BMC Infect Dis. 2016; 16: 391. PubMed | Google Scholar

  27. Iloh GU, Ikwudinma AO. Sero-epidemiology of Hepatitis B surface antigenaemia among adult Nigerians with clinical features of liver diseases attending a primary-care clinic in a resource-constrained setting of eastern Nigeria. North Am J Med Sci. 2013; 5(4): 293-300. PubMed | Google Scholar

  28. Ayele AG, Solomon GS. Prevalence and risk factors of Hepatitis B and Hepatitis C Virus Infections among Patients with Chronic Liver Diseases in Public Hospitals in Addis Ababa, Ethiopia. ISRN Tropical Med. 2013; 2013: 563821. Google Scholar

  29. Handady SO, Ahmed MA, Fadl AA, Alawad AAM. Precipitating factors of hepatic encephalopathy among Sudanese patients with Liver Cirrhosis. Medicine Journal. 2015; 2(4): 63-67. Google Scholar

  30. Patricia LG, Maria da PZG, Carla CM, Ana TM, Carlos SG, Fausto ELP. Etiology of liver cirrhosis in Brazil: chronic alcoholism and hepatitis viruses in liver cirrhosis diagnosed in the state of Espfrito Santo. Clinics. 2013; 68(3): 291-295. PubMed | Google Scholar

  31. Wolf DC; cirrhosis, Medscape, August 5th, 2013.

  32. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19•2 million participants. The Lancet. 2016; 387(10026): 1377-1396. PubMed | Google Scholar

  33. Lay CS, Tsai YT, Teg C, Shyu WS, Guo WS, Wu KL et al. Endoscopic vanceal prophylaxis of first variceal bleeding in cirrhotic patients (with high-risk esophageal varices. Hepatology. 1997; 25(6): 1346-1350. PubMed | Google Scholar

  34. Achinge I G, Malu AO, Okeke EN, Agaba EI, Misauno MA. Prevalence of oesophageal varices in newly diagnosed chronic liver disease patients at The Jos University Teaching Hospital, Jos. Nig Med J. 2011; 52(2): 128-132. Google Scholar

  35. Chalasani N, Imperiale TF, Ismail A, Sood G, Garey M, Wilcox CM et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol. 1999; 94(11): 3285-91. PubMed | Google Scholar